Characterization and Epigenetics of Post-Partum Preeclampsia



Status:Enrolling by invitation
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - 65
Updated:1/27/2018
Start Date:February 1, 2017
End Date:February 1, 2021

Use our guide to learn which trials are right for you!

This study will recruit women with post partum pre-eclampsia and match them to controls
without postpartum pre-eclampsia to identify an epigenetic signature that is specific to
women with post partum pre-eclampsia to help characterize the underlying pathophysiology of
post partum pre-eclampsia.

Preeclampsia (PEC) is a heterogeneous disease that complicates 5-8% of pregnancies.
Approximately 10% of PEC patients will present with post-partum PEC without having developed
the syndrome during the pregnancy (PP-PEC). Management of post-partum preeclampsia (PP-PEC)
is challenging because many women do not seek care until neurologic symptoms result from
severe-range elevated blood pressure. The pathogenesis and clinical characteristics of PP-PEC
are understudied and poorly understood. Identifying clinical risk factors and biomarkers of
PP-PEC would help to identify women at risk.

Inclusion Criteria:

- Post partum pre-eclampsia

Matching based on:

- maternal age (years +/-3)

- BMI (+/-5 points)

- Ethnicity

- Mode of delivery

- Gestational age at delivery (+/7 days)

- Smoking status

Exclusion Criteria:

- Intrapartum pre-eclampsia
We found this trial at
1
site
630 W 168th St
New York, New York
212-305-2862
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials